In a recent study published in the journal PLOS One, researchers present the crystal structure of an anti-non-structural protein 9 (nsp) specific nanobody in complex with the severe acute respiratory ...
HONG KONG, Mar 30, 2020 - (ACN Newswire) - - Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs ...
January 5, 2021, SEOUL, Korea - Cellid and the International Vaccine Institute (IVI) have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine ...
In a recent study posted to the bioRxiv* preprint server, researchers demonstrated the production of nanobodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback